Trial Profile
Influenza Vaccines: Mix and Match of Trivalent Inactivated Influenza (TIV) and Live Attenuated Influenza Vaccine (LAIV), a Phase I Safety, Immunogenicity, and Viral Shedding Study.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 May 2009
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine live (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 24 Jan 2008 Status changed from in progress to completed.
- 26 Jul 2007 Status changed from suspended to in progress.
- 05 Dec 2005 New trial record.